VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy

M. Tempero, A. Kessinger, H. M. Lemon

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Twenty-two patients with small-cell carcinoma of the lung who had failed combination chemotherapy were treated with VP-16-213 as a single agent. A partial remission was achieved in one patient. Twenty-three percent of the patients experienced arrest of disease for a median of 31 weeks. Leukopenia was a major complicating side effect.

Original languageEnglish (US)
Pages (from-to)155-157
Number of pages3
JournalCancer Clinical Trials
Volume4
Issue number2
StatePublished - 1981

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy'. Together they form a unique fingerprint.

  • Cite this